Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, Ireland, February 21, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/gcm8p2/life_sciences_bpo) has announced the addition of the "Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering.
Economic burden, increased financial crisis and technological advances has compelled all pharmaceutical, biotechnology and life science companies to outsource their R&D activities and manufacturing processes in order to achieve their cost benefits and save time.In recent years, large number of life science companies has modified their traditional drug manufacturing operations with more focus now on their core R&D activities and manufacturing processes via outsourcing. At present, new outsourcing strategies and types of services are developing in almost every stage of research and manufacturing process. For instance, a virtually integrated, cross-functional outsourcing of drug discovery research is currently being considered as a latest outsourcing model, especially for small molecule drug discovery. In addition, genomics & proteomics research and gene-silencing technology are now being widely used for target identification and validation of complex disease targets.
Global Life Sciences BPO market includes Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and others that compriseContract Sales Organization (CSO). The contract manufacturing organizations market is expected to see the highest growth rate during the forecast period and also accounted for the largest market share in the year 2012. This market holds immense growth owing to the rise in demand for generic drugs, increase in R&D investment by life sciences companies. In addition, a rise in the number of block buster drugs going off-patent and increased adoption of novel technologies are further boosting the growth of this market.
The CMO market comprises contract API (Active Pharmaceutical Ingredients) manufacturing, contract FDF (Finished Dosage Formulations) manufacturing and packaging.Among these, contract FDF manufacturing segment is expected to have a healthy growth rate during the forecast period. The CRO market is also expected to display a healthy growth rate after CMO market. The CRO market comprises of various segments such as drug discovery, pre-clinical studies, clinical trial phases, medical writing, clinical data management, pharmacovigilance, regulatory services, site management, protocol development, monitoring and bio-statistics. Among these, clinical data management segment is expected to have a strong growth rate in coming years. This growth has been attributed to its high data complexities, high cost involvement and requirement of skilled & trained professionals.
Key Topics Covered:
2 Executive Summary
3 Global Life Sciences BPO Market Dynamics
4 Global Life Sciences BPO Market, by Segments
5 Global Life Sciences BPO Market, by Geography
6 Global Life Sciences BPO Market Share Analysis
8 Company Profiles
9 List of the Companies
For more information visit http://www.researchandmarkets.com/research/gcm8p2/life_sciences_bpo
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
©2012 PR Newswire. All Rights Reserved.